say some lady did a PHD analysing the clinical.data for a pharmaceutical and found something interesting for investors in the associated biotech startup. Could said researcher contact institutional.investors with snippits of the information she has found and offer her consulting services to consider the market relevant information or would this be some kind of financially afoul thinh, or something investors wont really care about. for instead she may find that the drug is not as efficacious as the company has lead the public or investors to.believe and the regulatory authorities have approved it.anyway. I also wonder how likely a situation where an independent researcher finds something like this with public data is anyway?